Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2020

Open Access 01-12-2020 | Research article

Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off

Authors: Xiuying Wang, Lin Zhuo, Yifei Ma, Ting Cai, Aviva Must, Ling Xu, Lang Zhuo

Published in: BMC Medical Research Methodology | Issue 1/2020

Login to get access

Abstract

Background

Health-related quality of life (HRQoL) is often measured using EQ-5D-3L by the elicitation methods of visual analogue scale (VAS) and time trade-off (TTO). Although many countries have constructed both national VAS and TTO value sets, the fact that VAS and TTO value sets produces different values bewilders researchers and policymakers. The aim of this study is to explore certain conditions which could yield similar value sets using VAS and TTO.

Methods

A homogeneous sample of medical school students was selected to value 18 hypothetical health states using VAS and TTO methods. The 18 hypothetical health states were produced by orthogonal design (L18, 2*3^7). The range of rescaled values was transformed into − 1 ~ 0 ~ 1. The investigations via different methods were carried out by computer-assisted personal interviewing with a wash-time interval of 72 h. Value sets for VAS and TTO were constructed using general least square regression models. Independent variables were composed of 10 dummy variables from 5 dimensions and including or omitting both constant and N3 terms.

Results

Three hundred thirteen medical students participated. The mean age was 21.03 ± 0.44 years and 56.2% were female. The four regression models (for each method with and without constant and N3 terms) were all statistically significant (P < 0.05) with high goodness-of-fit (Adj. R2 > 0.94 and MAE < 0.033). Differences between the coefficients of the 10 dummy variables corresponding to each model were all less than 0.059. Pearson correlation coefficients between observed means and predicted values exceeded 0.981. Fitted curves of VAS and TTO largely coincided.

Conclusions

VAS and TTO can generate similar responses under certain conditions, suggesting that the two valuation methods could be equivalent intrinsically. The VAS method appears a more valid approach for valuation in the general population due to its greater simplicity and feasibility.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.CrossRef Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.CrossRef
2.
go back to reference Weernink MGM, Groothuis-Oudshoorn CGM, IJzerman MJ, van Til JA. Valuing treatments for Parkinson disease incorporating process utility: performance of best-worst scaling, time trade-off, and visual analogue scales. Value Health. 2016;19(2):226–32.PubMedCrossRef Weernink MGM, Groothuis-Oudshoorn CGM, IJzerman MJ, van Til JA. Valuing treatments for Parkinson disease incorporating process utility: performance of best-worst scaling, time trade-off, and visual analogue scales. Value Health. 2016;19(2):226–32.PubMedCrossRef
4.
go back to reference McDonough CM, Tosteson AN. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics. 2007;25(2):93–106.PubMedPubMedCentralCrossRef McDonough CM, Tosteson AN. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics. 2007;25(2):93–106.PubMedPubMedCentralCrossRef
5.
go back to reference Heintz E, Wirehn AB, Peebo BB, Rosenqvist U, Levin LA. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Value Health. 2012;15(3):475–84.PubMedCrossRef Heintz E, Wirehn AB, Peebo BB, Rosenqvist U, Levin LA. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Value Health. 2012;15(3):475–84.PubMedCrossRef
6.
go back to reference Haring R, Feng YS, Moock J, Volzke H, Dorr M, Nauck M, Wallaschofski H, Kohlmann T. Self-perceived quality of life predicts mortality risk better than a multi-biomarker panel, but the combination of both does best. BMC Med Res Methodol. 2011;11:103.PubMedPubMedCentralCrossRef Haring R, Feng YS, Moock J, Volzke H, Dorr M, Nauck M, Wallaschofski H, Kohlmann T. Self-perceived quality of life predicts mortality risk better than a multi-biomarker panel, but the combination of both does best. BMC Med Res Methodol. 2011;11:103.PubMedPubMedCentralCrossRef
7.
go back to reference Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, et al. A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ. 2003;4(3):222–31.PubMedCrossRef Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, et al. A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ. 2003;4(3):222–31.PubMedCrossRef
8.
go back to reference Crockett AJ, Cranston JM, Moss JR, Alpers JH. The MOS SF-36 health survey questionnaire in severe chronic airflow limitation: comparison with the Nottingham health profile. Qual Life Res. 1996;5(3):330–8.PubMedCrossRef Crockett AJ, Cranston JM, Moss JR, Alpers JH. The MOS SF-36 health survey questionnaire in severe chronic airflow limitation: comparison with the Nottingham health profile. Qual Life Res. 1996;5(3):330–8.PubMedCrossRef
9.
go back to reference Xia P, Li N, Hau KT, Liu C, Lu Y. Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF. BMC Med Res Methodol. 2012;12:37.PubMedPubMedCentralCrossRef Xia P, Li N, Hau KT, Liu C, Lu Y. Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF. BMC Med Res Methodol. 2012;12:37.PubMedPubMedCentralCrossRef
10.
go back to reference Mo F, Choi BC, Li FC, Merrick J. Using health utility index (HUI) for measuring the impact on health-related quality of life (HRQL) among individuals with chronic diseases. ScientificWorldJournal. 2004;4:746–57.PubMedPubMedCentralCrossRef Mo F, Choi BC, Li FC, Merrick J. Using health utility index (HUI) for measuring the impact on health-related quality of life (HRQL) among individuals with chronic diseases. ScientificWorldJournal. 2004;4:746–57.PubMedPubMedCentralCrossRef
11.
go back to reference Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res. 1982;30(6):1043–69.PubMedCrossRef Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res. 1982;30(6):1043–69.PubMedCrossRef
12.
go back to reference Hawthorne G, Richardson J, Day NA. A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Med. 2001;33(5):358–70.PubMedCrossRef Hawthorne G, Richardson J, Day NA. A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Med. 2001;33(5):358–70.PubMedCrossRef
13.
go back to reference Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006;9(4):213–8.PubMedCrossRef Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006;9(4):213–8.PubMedCrossRef
14.
go back to reference Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33(5):337–43.PubMedCrossRef Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33(5):337–43.PubMedCrossRef
15.
go back to reference Lee YJ, Lee S, Song S, Lee S, Suh D. Health utility in Myelofibrosis patients and comparison between health utility values measured by time trade off and visual analogue scale. Value Health. 2017;20(5):A115–6. Lee YJ, Lee S, Song S, Lee S, Suh D. Health utility in Myelofibrosis patients and comparison between health utility values measured by time trade off and visual analogue scale. Value Health. 2017;20(5):A115–6.
16.
go back to reference O'Boyle CJ, Royston CM, Sedman PC. Cost-utility analysis of open versus laparoscopic groin hernia repair: results from a multicentre randomized clinical trial (Br J Surg 2001; 88: 653-61). Br J Surg. 2001;88(11):1543–5.PubMedCrossRef O'Boyle CJ, Royston CM, Sedman PC. Cost-utility analysis of open versus laparoscopic groin hernia repair: results from a multicentre randomized clinical trial (Br J Surg 2001; 88: 653-61). Br J Surg. 2001;88(11):1543–5.PubMedCrossRef
17.
go back to reference Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, Burstrom K. Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey. Qual Life Res. 2008;20(3):309–20.CrossRef Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, Burstrom K. Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey. Qual Life Res. 2008;20(3):309–20.CrossRef
18.
go back to reference Tan Z, Liang Y, Liu S, Cao W, Tu H, Guo L, Xu Y. Health-related quality of life as measured with EQ-5D among populations with and without specific chronic conditions: a population-based survey in Shaanxi Province China. PloS one. 2013;8(7):e65958.PubMedPubMedCentralCrossRef Tan Z, Liang Y, Liu S, Cao W, Tu H, Guo L, Xu Y. Health-related quality of life as measured with EQ-5D among populations with and without specific chronic conditions: a population-based survey in Shaanxi Province China. PloS one. 2013;8(7):e65958.PubMedPubMedCentralCrossRef
19.
go back to reference Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O'Brien BJ. Are health states “timeless”? The case of the standard gamble method. J Clin Epidemiol. 1999;52(11):1047–53.PubMedCrossRef Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O'Brien BJ. Are health states “timeless”? The case of the standard gamble method. J Clin Epidemiol. 1999;52(11):1047–53.PubMedCrossRef
20.
go back to reference Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum E. Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med Decis Making. 2014;34(1):8–20.PubMedCrossRef Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum E. Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med Decis Making. 2014;34(1):8–20.PubMedCrossRef
21.
go back to reference Szende AG, Oppe M, Devlin NJ. EQ-5d value sets: inventory, comparative review and user guide; 2007. p. 1–102.CrossRef Szende AG, Oppe M, Devlin NJ. EQ-5d value sets: inventory, comparative review and user guide; 2007. p. 1–102.CrossRef
22.
go back to reference Burstrom K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–42.PubMedCrossRef Burstrom K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–42.PubMedCrossRef
23.
go back to reference Stavem K. Quality of life in epilepsy: comparison of four preference measures. Epilepsy Res. 1998;29(3):201–9.PubMedCrossRef Stavem K. Quality of life in epilepsy: comparison of four preference measures. Epilepsy Res. 1998;29(3):201–9.PubMedCrossRef
25.
go back to reference Cooper A, Wallman JK, Gulfe A. What PASSes for good? Experience-based Swedish and hypothetical British EuroQol 5-dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade. Scand J Rheumatol. 2016;45(6):470–3.PubMedCrossRef Cooper A, Wallman JK, Gulfe A. What PASSes for good? Experience-based Swedish and hypothetical British EuroQol 5-dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade. Scand J Rheumatol. 2016;45(6):470–3.PubMedCrossRef
26.
go back to reference Zrubka Z, Beretzky Z, Hermann Z, Brodszky V, Gulacsi L, Rencz F, Baji P, Golicki D, Prevolnik-Rupel V, Pentek M. A comparison of European, polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases. Eur J Health Econ. 2019;20(Suppl 1):119–32.PubMedPubMedCentralCrossRef Zrubka Z, Beretzky Z, Hermann Z, Brodszky V, Gulacsi L, Rencz F, Baji P, Golicki D, Prevolnik-Rupel V, Pentek M. A comparison of European, polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases. Eur J Health Econ. 2019;20(Suppl 1):119–32.PubMedPubMedCentralCrossRef
27.
go back to reference Mendeloff J. Measuring elusive benefits: on the value of health. J Health Polit Policy Law. 1983;8(3):554–80.PubMedCrossRef Mendeloff J. Measuring elusive benefits: on the value of health. J Health Polit Policy Law. 1983;8(3):554–80.PubMedCrossRef
28.
go back to reference De Wit GA, Busschbach JJ, De Charro FT. Sensitivity and perspective in the valuation of health status: whose values count? Health Econ. 2000;9(2):109–26.PubMedCrossRef De Wit GA, Busschbach JJ, De Charro FT. Sensitivity and perspective in the valuation of health status: whose values count? Health Econ. 2000;9(2):109–26.PubMedCrossRef
29.
go back to reference Craig BM, Busschbach JJ, Salomon JA. Keep it simple: ranking health states yields values similar to cardinal measurement approaches. J Clin Epidemiol. 2009;62(3):296–305.PubMedCrossRef Craig BM, Busschbach JJ, Salomon JA. Keep it simple: ranking health states yields values similar to cardinal measurement approaches. J Clin Epidemiol. 2009;62(3):296–305.PubMedCrossRef
30.
go back to reference Craig BM, Busschbach JJ, Salomon JA. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods. Med Care. 2009;47(6):634–41.PubMedPubMedCentralCrossRef Craig BM, Busschbach JJ, Salomon JA. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods. Med Care. 2009;47(6):634–41.PubMedPubMedCentralCrossRef
31.
go back to reference Green C, Brazier J, Deverill M. Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics. 2000;17(2):151–65.PubMedCrossRef Green C, Brazier J, Deverill M. Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics. 2000;17(2):151–65.PubMedCrossRef
32.
go back to reference Lamers LM. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med Care. 2007;45(3):238–44.PubMedCrossRef Lamers LM. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med Care. 2007;45(3):238–44.PubMedCrossRef
33.
go back to reference Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making. 2008;28(1):66–89.PubMedCrossRef Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making. 2008;28(1):66–89.PubMedCrossRef
34.
go back to reference Chevalier J, de Pouvourville G. Valuing EQ-5D using time trade-off in France. Eur J Health Econ. 2013;14(1):57–66.PubMedCrossRef Chevalier J, de Pouvourville G. Valuing EQ-5D using time trade-off in France. Eur J Health Econ. 2013;14(1):57–66.PubMedCrossRef
35.
go back to reference Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–32.PubMedCrossRef Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–32.PubMedCrossRef
36.
37.
go back to reference Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goni JM, Luo N. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34(10):993–1004.PubMedPubMedCentralCrossRef Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goni JM, Luo N. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34(10):993–1004.PubMedPubMedCentralCrossRef
38.
go back to reference Bailey H, Kind P, La Foucade A. Results from an exploratory study to test the performance of EQ-5D-3L valuation subsets based on orthogonal designs, and an investigation into some modeling and transformation alternatives for the utility function. Heal Econ Rev. 2014;4(1):29.CrossRef Bailey H, Kind P, La Foucade A. Results from an exploratory study to test the performance of EQ-5D-3L valuation subsets based on orthogonal designs, and an investigation into some modeling and transformation alternatives for the utility function. Heal Econ Rev. 2014;4(1):29.CrossRef
39.
go back to reference Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Effect of health state sampling methods on model predictions of EQ-5D-5L values: small designs can suffice. Value Health. 2019;22(1):38–44.PubMedCrossRef Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Effect of health state sampling methods on model predictions of EQ-5D-5L values: small designs can suffice. Value Health. 2019;22(1):38–44.PubMedCrossRef
41.
go back to reference Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604.PubMedCrossRef Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604.PubMedCrossRef
42.
go back to reference Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17(4):445–53.PubMedCrossRef Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17(4):445–53.PubMedCrossRef
43.
go back to reference Zhuo L, Xu L, Ye J, Sun S, Zhang Y, Burstrom K, Chen J. Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey. Value Health. 2018;21(11):1330–7.PubMedCrossRef Zhuo L, Xu L, Ye J, Sun S, Zhang Y, Burstrom K, Chen J. Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey. Value Health. 2018;21(11):1330–7.PubMedCrossRef
44.
go back to reference Augestad LA, Rand-Hendriksen K, Stavem K, Kristiansen IS. Time trade-off and attitudes toward euthanasia: implications of using ‘death’ as an anchor in health state valuation. Qual Life Res. 2013;22(4):705–14.PubMedCrossRef Augestad LA, Rand-Hendriksen K, Stavem K, Kristiansen IS. Time trade-off and attitudes toward euthanasia: implications of using ‘death’ as an anchor in health state valuation. Qual Life Res. 2013;22(4):705–14.PubMedCrossRef
45.
go back to reference Lee BS, Kymes SM, Nease RF Jr, Sumner W, Siegfried CJ, Gordon MO. The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology. 2008;115(5):898–903 e894.PubMedCrossRef Lee BS, Kymes SM, Nease RF Jr, Sumner W, Siegfried CJ, Gordon MO. The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology. 2008;115(5):898–903 e894.PubMedCrossRef
46.
go back to reference Lee JY, Lee E. Assessment of utility for heart failure using visual analogue scale (vas), time-trade off (Tto) and Euroqol-5 dimension (Eq-5d) in the Korean general population. Value Health. 2016;19(7):A868–9.CrossRef Lee JY, Lee E. Assessment of utility for heart failure using visual analogue scale (vas), time-trade off (Tto) and Euroqol-5 dimension (Eq-5d) in the Korean general population. Value Health. 2016;19(7):A868–9.CrossRef
47.
go back to reference Stiggelbout AM, Eijkemans MJC, Kiebert GM, Kievit J, Leer JWH, DeHaes HJCJM. The 'utility' of the visual analog scale in medical decision making and technology assessment - is it an alternative to the time trade-off? Int J Technol Assess Health Care. 1996;12(2):291–8.PubMedCrossRef Stiggelbout AM, Eijkemans MJC, Kiebert GM, Kievit J, Leer JWH, DeHaes HJCJM. The 'utility' of the visual analog scale in medical decision making and technology assessment - is it an alternative to the time trade-off? Int J Technol Assess Health Care. 1996;12(2):291–8.PubMedCrossRef
48.
go back to reference Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF. Review of 103 Swedish healthcare quality registries. J Intern Med. 2014. Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF. Review of 103 Swedish healthcare quality registries. J Intern Med. 2014.
49.
go back to reference Jin X, Liu GG, Luo N, Li H, Guan H, Xie F. Is bad living better than good death? Impact of demographic and cultural factors on health state preference. Qual Life Res. 2016;25(4):979–86.PubMedCrossRef Jin X, Liu GG, Luo N, Li H, Guan H, Xie F. Is bad living better than good death? Impact of demographic and cultural factors on health state preference. Qual Life Res. 2016;25(4):979–86.PubMedCrossRef
50.
go back to reference Yin Z, Li J, Ma K, Ning X, Chen H, Fu H, Zhang H, Wang C, Bruera E, Hui D. Development of palliative Care in China: a tale of three cities. Oncologist. 2017;22(11):1362–7.PubMedPubMedCentralCrossRef Yin Z, Li J, Ma K, Ning X, Chen H, Fu H, Zhang H, Wang C, Bruera E, Hui D. Development of palliative Care in China: a tale of three cities. Oncologist. 2017;22(11):1362–7.PubMedPubMedCentralCrossRef
51.
go back to reference Seymour J, McNamee P, Scott A, Tinelli M. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ. 2010;19(6):683–96.PubMed Seymour J, McNamee P, Scott A, Tinelli M. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ. 2010;19(6):683–96.PubMed
52.
go back to reference Ramos-Goni JM, Pinto-Prades JL, Oppe M, Cabases JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2014;55:e51–8.CrossRef Ramos-Goni JM, Pinto-Prades JL, Oppe M, Cabases JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2014;55:e51–8.CrossRef
53.
go back to reference Scalone L, Cortesi PA, Ciampichini R, Belisari A, D'Angiolella LS, Cesana G, Mantovani LG. Italian population-based values of EQ-5D health states. Value Health. 2013;16(5):814–22.PubMedCrossRef Scalone L, Cortesi PA, Ciampichini R, Belisari A, D'Angiolella LS, Cesana G, Mantovani LG. Italian population-based values of EQ-5D health states. Value Health. 2013;16(5):814–22.PubMedCrossRef
54.
go back to reference Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health. 2009;37(5):459–66.PubMedCrossRef Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health. 2009;37(5):459–66.PubMedCrossRef
55.
go back to reference Andrade MV, Noronha K, Kind P, Reis Cde B, de Carvalho LR. Logical inconsistencies in 3 preference elicitation methods for EQ-5D health states: a study in the Brazilian population. Med Decis Making. 2016;36(2):242–52.PubMedCrossRef Andrade MV, Noronha K, Kind P, Reis Cde B, de Carvalho LR. Logical inconsistencies in 3 preference elicitation methods for EQ-5D health states: a study in the Brazilian population. Med Decis Making. 2016;36(2):242–52.PubMedCrossRef
56.
go back to reference Sun S, Chen J, Kind P, Xu L, Zhang Y, Burstrom K. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Qual Life Res. 2015;24(3):693–703.PubMedCrossRef Sun S, Chen J, Kind P, Xu L, Zhang Y, Burstrom K. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Qual Life Res. 2015;24(3):693–703.PubMedCrossRef
57.
go back to reference Badia X, Monserrat S, Roset M, Herdman M. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res. 1999;8(4):303–10.PubMedCrossRef Badia X, Monserrat S, Roset M, Herdman M. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res. 1999;8(4):303–10.PubMedCrossRef
Metadata
Title
Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off
Authors
Xiuying Wang
Lin Zhuo
Yifei Ma
Ting Cai
Aviva Must
Ling Xu
Lang Zhuo
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2020
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-020-01008-9

Other articles of this Issue 1/2020

BMC Medical Research Methodology 1/2020 Go to the issue